264 related articles for article (PubMed ID: 27097388)
1. Cauterization for epistaxis in hereditary hemorrhagic telangiectasia.
Dabiri J; Fakhoury R; Choufani G; Mine B; Hassid S
B-ENT; 2016; 12(1):9-16. PubMed ID: 27097388
[TBL] [Abstract][Full Text] [Related]
2. Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization.
Trojanowski P; Jargiello T; Trojanowska A; Klatka J
Acta Radiol; 2011 Oct; 52(8):846-9. PubMed ID: 21816895
[TBL] [Abstract][Full Text] [Related]
3. Clinical Practice Guideline: Nosebleed (Epistaxis).
Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
Otolaryngol Head Neck Surg; 2020 Jan; 162(1_suppl):S1-S38. PubMed ID: 31910111
[TBL] [Abstract][Full Text] [Related]
4. Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.
Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
Otolaryngol Head Neck Surg; 2020 Jan; 162(1):8-25. PubMed ID: 31910122
[TBL] [Abstract][Full Text] [Related]
5. [Embolization of branches of the external carotid artery in nosebleeds complicating Rendu-Osler-Weber disease].
Nekipelov EF; Serbinenko FA
Zh Vopr Neirokhir Im N N Burdenko; 1983; (4):23-33. PubMed ID: 6624354
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis.
Braak SJ; de Witt CA; Disch FJ; Overtoom TT; Westermann JJ
Rhinology; 2009 Jun; 47(2):166-71. PubMed ID: 19593974
[TBL] [Abstract][Full Text] [Related]
7. Endovascular treatment of epistaxis: indications, management, and outcome.
Strach K; Schröck A; Wilhelm K; Greschus S; Tschampa H; Möhlenbruch M; Naehle CP; Jakob M; Gerstner AO; Bootz F; Schild HH; Urbach H
Cardiovasc Intervent Radiol; 2011 Dec; 34(6):1190-8. PubMed ID: 21472510
[TBL] [Abstract][Full Text] [Related]
8. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
Hanks JE; Hunter D; Goding GS; Boyer HC
Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
[TBL] [Abstract][Full Text] [Related]
9. Endovascular treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia.
Layton KF; Kallmes DF; Gray LA; Cloft HJ
AJNR Am J Neuroradiol; 2007 May; 28(5):885-8. PubMed ID: 17494663
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a topical sesame/rose geranium oil compound in patients with hereditary hemorrhagic telangiectasia associated epistaxis.
Reh DD; Hur K; Merlo CA
Laryngoscope; 2013 Apr; 123(4):820-2. PubMed ID: 23401038
[TBL] [Abstract][Full Text] [Related]
11. A silicone nasal swab for the treatment of severe and recalcitrant epistaxis in hereditary hemorrhagic telangiectasia: an alternative to surgical nostril closure.
Bruschini L; Seccia V; Dallan I
Am J Otolaryngol; 2011; 32(4):301-3. PubMed ID: 20719406
[TBL] [Abstract][Full Text] [Related]
12. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ
J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556
[TBL] [Abstract][Full Text] [Related]
13. Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management.
Sautter NB; Smith TL
Int Forum Allergy Rhinol; 2012; 2(5):422-31. PubMed ID: 22566463
[TBL] [Abstract][Full Text] [Related]
14. Randomized, controlled, double-blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization.
Khanwalkar AR; Rathor A; Read AK; Paknezhad H; Ma Y; Hwang PH
Int Forum Allergy Rhinol; 2022 Aug; 12(8):1034-1042. PubMed ID: 34989143
[TBL] [Abstract][Full Text] [Related]
15. [Intractable epistaxis in Osler-Rendu-Weber syndrome].
Zalagh M; Errami N; Bouaity B; Hemmaoui B; Itoua W; Benariba F
Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):310-2. PubMed ID: 21940027
[TBL] [Abstract][Full Text] [Related]
16. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia.
Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA
Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959
[TBL] [Abstract][Full Text] [Related]
17. [Treatments of hereditary hemorrhagic telangiectasia of the nasal mucosa].
Babin E; Borsik M; Braccard S; Crampette L; Darrouzet V; Faure F; Fontanel JP; Houdart E; Jankowski R; Le Clech G; Malvezzi L; Morinière S; Perie S; Perret J; Pignat JC; Portier F; Serrano E; Plauchu H
Rev Laryngol Otol Rhinol (Bord); 2005; 126(1):43-8. PubMed ID: 16080648
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous embolization to control epistaxis in Rendu-Osler-Weber disease.
Strother CM; Newton TH
Arch Otolaryngol; 1976 Jan; 102(1):58-60. PubMed ID: 1244834
[TBL] [Abstract][Full Text] [Related]
19. ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
Dupuis-Girod S; Ambrun A; Decullier E; Samson G; Roux A; Fargeton AE; Rioufol C; Schwiertz V; Disant F; Chapuis F; Donazzolo Y; Paintaud G; Edery P; Faure F
MAbs; 2014; 6(3):794-9. PubMed ID: 24481211
[TBL] [Abstract][Full Text] [Related]
20. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
